Previous mechanistic studies have shown that the improvement of dyslipidemia induced by a ketogenic diet may not only benefit the regulation of insulin sensitivity, but also control and prevent the occurrence and progression of related complications [49,50]. This evidence concerns the gene INS and metabolic syndrome.